Aim Head and neck cancers are the eighth most common cancer worldwide. Despite significant ad- vances in the delivery of treatment and surgical reconstruction, the mortality rates for this disease have not improved in...Aim Head and neck cancers are the eighth most common cancer worldwide. Despite significant ad- vances in the delivery of treatment and surgical reconstruction, the mortality rates for this disease have not improved in the past 4 decades. Our previous study has shown that HIV protease inhibitors （HIV PIs） induce cell apoptosis via activating endoplasmic reticulum （ER） stress. It also has been reported that a few HIV PIs are able to radio- sensitize tumor cells. However, the underlying cellular mechanisms remain to be identified. The aim of this study was to examine whether HIV PIs activate the ER stress response and sensitize human head and neck carcinoma cells to radiation. Methods Human SQ20B and Fadu cells and the most commonly used HIV PIs, lopinavir and ritona- vir, were used in this study. The mRNA and protein levels of ER stress-related genes （ CHOP, ATF4, XBP-1, and GRP78 ） were detected by real time RT-PCR and Western blot, respectively. Cell viability and apoptosis were ana- lyzed using Cellometer Vision CBA. After treatment with HIV PIs, cells were irradiated at a dose of 2G or 4G. Col- onies were stained and counted 10 days after irradiation. Results HIV PIs significantly induced activation of ER stress and apoptosis. Treatment of HIV PIs inhibited Akt phosphorylation, induced cell cycle arrest in G1 phase and increased tumor cell sensitivity to irradiation-induced cell death. Conclusion HIV PIs sensitize human head and neck carcinoma cells to radiation by activating ER stress.展开更多
Objective: To compare preterm delivery (PTD) rates in HIV-infected patients on a protease inhibitor (PI)-based and a PI-sparing regimen. Study Design: This is a retrospective review of records of HIV-infected pregnant...Objective: To compare preterm delivery (PTD) rates in HIV-infected patients on a protease inhibitor (PI)-based and a PI-sparing regimen. Study Design: This is a retrospective review of records of HIV-infected pregnant women between 2000 and 2007 at University Hospital, Newark, NJ. Patients were grouped according to PI exposure during pregnancy. Rates of preterm birth were compared, and the analysis was performed irrespectively of the etiology or indication of the preterm birth. Multivariate analysis including substance use, PI use, initial CD4 count, and history of PTD was performed. Results: There were 129 pregnant women in the PI group and 59 in the PI-sparing group. The PTD rate did not differ between the PI group and PI-sparing group (27.9% vs 25.4%, P = 0.72). 28.6% of those who delivered preterm had a previous PTD compared to 8.4% of those who delivered at term (P = 0.0019). Patients who delivered preterm had a higher rate of substance use (37.3% vs 19.7%, P = 0.0128). In the multivariate analysis, only history of PTD was significant (P = 0.018). Conclusion: Contrary to other studies, PIs were not associated with PTD. Other known risk factors of PTD, specifically past PTD and substance use, should be considered and targeted for risk reduction during pregnancy.展开更多
Objective: To survey the level and patterns of reverse transcriptase-based drug resistance and subtype distribution among antiretroviral-treated HIV-infected patients receiving only reverse transcriptase inhibitors in...Objective: To survey the level and patterns of reverse transcriptase-based drug resistance and subtype distribution among antiretroviral-treated HIV-infected patients receiving only reverse transcriptase inhibitors in Iran.Methods: A total of 25 samples of antiretroviral therapy experienced patients with no history of using protease inhibitors were collected. After RNA extraction, reverse transcriptase-nested PCR was performed. The final products were sequenced and then analysed for drug-resistant mutations and subtypes.Results: No drug resistant mutations were observed among the 25 subjects. The results showed the following subtypes among patients: CRF 35_AD(88%), CRF 28_BF(8%),and CRF 29_BF(4%).Conclusions: A significant increase in drug resistance has been noted in recentlyinfected patients worldwide. Subtype distributions are needed to perform properlydesigned surveillance studies to continuously monitor rates and patterns of transmitted drug resistance and subtypes to help guide therapeutic approaches and limit transmission of these variants.展开更多
目的:运用计算机虚拟筛选技术从传统中药数据库(TCMSP)中快速搜索HIV-1蛋白酶(Protease,PR)的中药小分子抑制剂。方法:采用Scripps研究所的Auto Dock Vina软件,对蛋白质晶体结构数据库PDB中PR与小分子抑制剂沙奎那韦(Saquinavir)形成的...目的:运用计算机虚拟筛选技术从传统中药数据库(TCMSP)中快速搜索HIV-1蛋白酶(Protease,PR)的中药小分子抑制剂。方法:采用Scripps研究所的Auto Dock Vina软件,对蛋白质晶体结构数据库PDB中PR与小分子抑制剂沙奎那韦(Saquinavir)形成的复合物(PDB代码:1HXB)三维结构活性部位进行分析,基于传统中药配体库进行分子对接初次筛选。综合运用传统中药系统药理学数据库及分析平台TCMSP及Accelrys公司开发的Discovery Studio 2.5分子模拟软件包内TOPKAT模块计算药代动力学参数和毒性预测对分子对接结果进行2次筛选。结果:以原配体(沙奎那韦)为阳性对照,筛选出传统中药库TCMSP中2个类药性良好的化学成分与PR亲和力高于上市的抗艾滋病药物沙奎那韦的天然小分子化合物,并且确定了它们的中草药来源。结论:该研究结果可促进从传统中药库中提取、设计以及实验合成新的抗艾滋病药物。展开更多
文摘Aim Head and neck cancers are the eighth most common cancer worldwide. Despite significant ad- vances in the delivery of treatment and surgical reconstruction, the mortality rates for this disease have not improved in the past 4 decades. Our previous study has shown that HIV protease inhibitors （HIV PIs） induce cell apoptosis via activating endoplasmic reticulum （ER） stress. It also has been reported that a few HIV PIs are able to radio- sensitize tumor cells. However, the underlying cellular mechanisms remain to be identified. The aim of this study was to examine whether HIV PIs activate the ER stress response and sensitize human head and neck carcinoma cells to radiation. Methods Human SQ20B and Fadu cells and the most commonly used HIV PIs, lopinavir and ritona- vir, were used in this study. The mRNA and protein levels of ER stress-related genes （ CHOP, ATF4, XBP-1, and GRP78 ） were detected by real time RT-PCR and Western blot, respectively. Cell viability and apoptosis were ana- lyzed using Cellometer Vision CBA. After treatment with HIV PIs, cells were irradiated at a dose of 2G or 4G. Col- onies were stained and counted 10 days after irradiation. Results HIV PIs significantly induced activation of ER stress and apoptosis. Treatment of HIV PIs inhibited Akt phosphorylation, induced cell cycle arrest in G1 phase and increased tumor cell sensitivity to irradiation-induced cell death. Conclusion HIV PIs sensitize human head and neck carcinoma cells to radiation by activating ER stress.
文摘Objective: To compare preterm delivery (PTD) rates in HIV-infected patients on a protease inhibitor (PI)-based and a PI-sparing regimen. Study Design: This is a retrospective review of records of HIV-infected pregnant women between 2000 and 2007 at University Hospital, Newark, NJ. Patients were grouped according to PI exposure during pregnancy. Rates of preterm birth were compared, and the analysis was performed irrespectively of the etiology or indication of the preterm birth. Multivariate analysis including substance use, PI use, initial CD4 count, and history of PTD was performed. Results: There were 129 pregnant women in the PI group and 59 in the PI-sparing group. The PTD rate did not differ between the PI group and PI-sparing group (27.9% vs 25.4%, P = 0.72). 28.6% of those who delivered preterm had a previous PTD compared to 8.4% of those who delivered at term (P = 0.0019). Patients who delivered preterm had a higher rate of substance use (37.3% vs 19.7%, P = 0.0128). In the multivariate analysis, only history of PTD was significant (P = 0.018). Conclusion: Contrary to other studies, PIs were not associated with PTD. Other known risk factors of PTD, specifically past PTD and substance use, should be considered and targeted for risk reduction during pregnancy.
基金The study protocol was performed according to the Helsinki Declaration and approved by Tarbiat Modares University ethical committee(Reg No.1389-9).
文摘Objective: To survey the level and patterns of reverse transcriptase-based drug resistance and subtype distribution among antiretroviral-treated HIV-infected patients receiving only reverse transcriptase inhibitors in Iran.Methods: A total of 25 samples of antiretroviral therapy experienced patients with no history of using protease inhibitors were collected. After RNA extraction, reverse transcriptase-nested PCR was performed. The final products were sequenced and then analysed for drug-resistant mutations and subtypes.Results: No drug resistant mutations were observed among the 25 subjects. The results showed the following subtypes among patients: CRF 35_AD(88%), CRF 28_BF(8%),and CRF 29_BF(4%).Conclusions: A significant increase in drug resistance has been noted in recentlyinfected patients worldwide. Subtype distributions are needed to perform properlydesigned surveillance studies to continuously monitor rates and patterns of transmitted drug resistance and subtypes to help guide therapeutic approaches and limit transmission of these variants.
文摘目的:运用计算机虚拟筛选技术从传统中药数据库(TCMSP)中快速搜索HIV-1蛋白酶(Protease,PR)的中药小分子抑制剂。方法:采用Scripps研究所的Auto Dock Vina软件,对蛋白质晶体结构数据库PDB中PR与小分子抑制剂沙奎那韦(Saquinavir)形成的复合物(PDB代码:1HXB)三维结构活性部位进行分析,基于传统中药配体库进行分子对接初次筛选。综合运用传统中药系统药理学数据库及分析平台TCMSP及Accelrys公司开发的Discovery Studio 2.5分子模拟软件包内TOPKAT模块计算药代动力学参数和毒性预测对分子对接结果进行2次筛选。结果:以原配体(沙奎那韦)为阳性对照,筛选出传统中药库TCMSP中2个类药性良好的化学成分与PR亲和力高于上市的抗艾滋病药物沙奎那韦的天然小分子化合物,并且确定了它们的中草药来源。结论:该研究结果可促进从传统中药库中提取、设计以及实验合成新的抗艾滋病药物。
